These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32779276)

  • 1. Risk of major depressive disorder in Japanese cancer patients: A matched cohort study using employer-based health insurance claims data.
    Akechi T; Mishiro I; Fujimoto S; Murase K
    Psychooncology; 2020 Oct; 29(10):1686-1694. PubMed ID: 32779276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of major depressive disorder in adolescent and young adult cancer patients in Japan.
    Akechi T; Mishiro I; Fujimoto S
    Psychooncology; 2022 Jun; 31(6):929-937. PubMed ID: 35001472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Major Depressive Disorder in Japanese Patients with Cancer: A Matched Cohort Study Using Employer-Based Health Insurance Claims Data.
    Akechi T; Fujimoto S; Mishiro I; Murase K
    Clin Drug Investig; 2020 Dec; 40(12):1115-1125. PubMed ID: 33070280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diseases prevalent before major depressive disorder diagnosis: an exploratory nested case-control study using health insurance-based claims data.
    Cho Y; Mishiro I; Akaki T; Akimoto T; Fujikawa K
    BMJ Open; 2022 Feb; 12(2):e048233. PubMed ID: 35168961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of hypnotic prescribing for residual insomnia and recurrence of major depressive disorder: a retrospective cohort study using a Japanese health insurance claims database.
    Yamato K; Inada K; Enomoto M; Marumoto T; Takeshima M; Mishima K
    BMC Psychiatry; 2021 Jan; 21(1):40. PubMed ID: 33441086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk for major depressive disorder in severely obese patients after bariatric surgery - a 12-year nationwide cohort study.
    Lu CW; Chang YK; Lee YH; Kuo CS; Chang HH; Huang CT; Hsu CC; Huang KC
    Ann Med; 2018 Nov; 50(7):605-612. PubMed ID: 30101619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major depressive disorder increased risk of psoriasis: A propensity score matched cohort study.
    Chen YH; Wang WM; Li IH; Kao HH; Yeh CB; Kao LT
    J Affect Disord; 2021 Jan; 278():407-412. PubMed ID: 33010565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Depression Onset and Treatment on the Trend of Annual Medical Costs in Japan: An Exploratory, Descriptive Analysis of Employer-Based Health Insurance Claims Data.
    Cho Y; Mishiro I; Fujimoto S; Nakajima T
    Adv Ther; 2022 Apr; 39(4):1553-1566. PubMed ID: 34729704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance.
    Ivanova JI; Birnbaum HG; Chen L; Duhig AM; Dayoub EJ; Kantor ES; Schiller MB; Phillips GA
    Am J Manag Care; 2011 Aug; 17(8):e314-23. PubMed ID: 21851139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in patients with major depressive disorder: A nationwide population-based cohort study with 11-year follow-up.
    Bitter I; Szekeres G; Cai Q; Feher L; Gimesi-Orszagh J; Kunovszki P; El Khoury AC; Dome P; Rihmer Z
    Eur Psychiatry; 2024 Sep; 67(1):e63. PubMed ID: 39344202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
    Valuck RJ; Libby AM; Sills MR; Giese AA; Allen RR
    CNS Drugs; 2004; 18(15):1119-32. PubMed ID: 15581382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prevalence and Regional Variation of Major Depressive Disorder Among Patients With Peripheral Arterial Disease in the Medicare Population.
    Columbo JA; Stone DH; Goodney PP; Nolan BW; Stableford JA; Brooke BS; Powell RJ; Finn CT
    Vasc Endovascular Surg; 2016 May; 50(4):235-40. PubMed ID: 27207676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
    Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
    PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic medical conditions and metabolic syndrome as risk factors for incidence of major depressive disorder: A longitudinal study based on 4.7 million adults in South Korea.
    Han KM; Kim MS; Kim A; Paik JW; Lee J; Ham BJ
    J Affect Disord; 2019 Oct; 257():486-494. PubMed ID: 31319340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Major Depressive Disorder: Variation by Age and Sex in Low-Income Individuals: A Population-Based 10-Year Follow-Up Study.
    Lee CT; Chiang YC; Huang JY; Tantoh DM; Nfor ON; Lee JF; Chang CC; Liaw YP
    Medicine (Baltimore); 2016 Apr; 95(15):e3110. PubMed ID: 27082549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata.
    Vallerand IA; Lewinson RT; Parsons LM; Hardin J; Haber RM; Lowerison MW; Barnabe C; Patten SB
    JAMA Dermatol; 2019 Apr; 155(4):475-479. PubMed ID: 30649133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up.
    Widom CS; DuMont K; Czaja SJ
    Arch Gen Psychiatry; 2007 Jan; 64(1):49-56. PubMed ID: 17199054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major depressive disorder with subthreshold hypomanic (mixed) features: A real-world assessment of treatment patterns and economic burden.
    McIntyre RS; Ng-Mak D; Chuang CC; Halpern R; Patel PA; Rajagopalan K; Loebel A
    J Affect Disord; 2017 Mar; 210():332-337. PubMed ID: 28073041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.